We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$383M
AUM Growth
-$117M
Cap. Flow
-$117M
Cap. Flow %
-30.64%
Top 10 Hldgs %
12.47%
Holding
686
New
221
Increased
70
Reduced
96
Closed
299

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$5.55M
2
AAPL icon
Apple
AAPL
+$5.2M
3
BX icon
Blackstone
BX
+$5.14M
4
XOM icon
ExxonMobil
XOM
+$4.86M
5
CPNG icon
Coupang
CPNG
+$4.77M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$7.71M
2
IBM icon
IBM
IBM
+$7.01M
3
AMZN icon
Amazon
AMZN
+$7M
4
META icon
Meta Platforms (Facebook)
META
+$7M
5
ADBE icon
Adobe
ADBE
+$6.69M

Sector Composition

Rank Sector Weight
1 Technology 20.66%
2 Consumer Discretionary 18.8%
3 Healthcare 15.72%
4 Financials 9.59%
5 Industrials 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFC icon
176
Manulife Financial
MFC
$73.9B
$663K 0.17%
+37,171
New +$634K
LW icon
177
Lamb Weston
LW
$7.22B
$661K 0.17%
+7,402
New +$630K
ADSK icon
178
Autodesk
ADSK
$49.5B
$659K 0.17%
+3,524
New +$707K
CCEP icon
179
Coca-Cola Europacific Partners
CCEP
$48.3B
$654K 0.17%
+11,822
New +$593K
AON icon
180
Aon
AON
$76.5B
$652K 0.17%
+2,171
New +$634K
TEVA icon
181
Teva Pharmaceuticals
TEVA
$40.8B
$650K 0.17%
+71,297
New +$622K
WGO icon
182
Winnebago Industries
WGO
$856M
$648K 0.17%
+12,293
New +$699K
SILK
183
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$640K 0.17%
+12,112
New +$590K
HAPN
184
Happen Inc
HAPN
$2.21B
$629K 0.16%
71,500
-2,511
-3% -$25.9K
AVGO icon
185
Broadcom
AVGO
$1.85T
$627K 0.16%
+11,210
New +$562K
ENTG icon
186
Entegris
ENTG
$18.1B
$624K 0.16%
+9,507
New +$700K
BCE icon
187
BCE
BCE
$20.2B
$622K 0.16%
14,146
-6,042
-30% -$272K
MDRX
188
DELISTED
Veradigm Inc. Common Stock
MDRX
$620K 0.16%
+35,169
New +$589K
GMAB icon
189
Genmab
GMAB
$17.7B
$615K 0.16%
+14,511
New +$598K
HMC icon
190
Honda
HMC
$39.1B
$610K 0.16%
+26,674
New +$618K
STAA icon
191
STAAR Surgical
STAA
$1.21B
$605K 0.16%
+12,458
New +$781K
ACGL icon
192
Arch Capital
ACGL
$34.3B
$603K 0.16%
9,609
-2,003
-17% -$112K
PCVX icon
193
Vaxcyte
PCVX
$7.81B
$602K 0.16%
+12,561
New +$493K
PTC icon
194
PTC
PTC
$15.8B
$602K 0.16%
+5,014
New +$600K
TDG icon
195
TransDigm Group
TDG
$70.2B
$599K 0.16%
952
+493
+107% +$290K
STX icon
196
Seagate
STX
$194B
$596K 0.16%
+11,327
New +$602K
TRI icon
197
Thomson Reuters
TRI
$42.8B
$592K 0.15%
4,924
+1,453
+42% +$167K
KO icon
198
Coca-Cola
KO
$377B
$590K 0.15%
9,272
-29,639
-76% -$1.79M
PLTR icon
199
Palantir
PLTR
$295B
$579K 0.15%
90,257
-124,837
-58% -$946K
TE
200
T1 Energy
TE
$1.16B
$576K 0.15%
+66,316
New +$831K

Similar funds

Seven Eight Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Seven Eight Capital held 686 positions worth $383M, down 23% from $500M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Seven Eight Capital withdrew a net $117M in Q4 2022, closing 299 positions and reducing 96 holdings. Its most notable exit was IBM, an estimated $7.01M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Seven Eight Capital opened a new position in Blackstone worth $4.42M.

  • Seven Eight Capital's largest Q4 2022 buy was Blackstone: 59,535 shares worth $4.42M.
  • Seven Eight Capital added most to CrowdStrike in Q4 2022, an estimated $5.55M increase.
  • Seven Eight Capital's biggest Q4 2022 reduction was Mastercard, cutting an estimated $7.71M.
  • Seven Eight Capital fully exited IBM in Q4 2022, selling an estimated $7.01M.
  • Seven Eight Capital's ten largest holdings make up 12% of its $383M portfolio in Q4 2022.
  • Seven Eight Capital opened 221 new positions and closed 299 in Q4 2022.
  • Seven Eight Capital's portfolio value fell 23% quarter-over-quarter to $383M.

Based on Seven Eight Capital's 13F filing for Q4 2022, filed 13 Feb 2023.